Variable phenotypes in velocardiofacial syndrome with chromosomal deletion.

PubWeight™: 1.38‹?› | Rank: Top 10%

🔗 View Article (PMID 8355116)

Published in J Pediatr on September 01, 1993

Authors

B Motzkin1, R Marion, R Goldberg, R Shprintzen, P Saenger

Author Affiliations

1: Department of Pediatrics, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, New York 10467.

Articles citing this

"CATCH 22" sans cardiac anomaly, thymic hypoplasia, cleft palate, and hypocalcaemia: cAtch 22. A common result of 22q11 deficiency? J Med Genet (1994) 2.69

22q11 deletion syndrome: a genetic subtype of schizophrenia. Biol Psychiatry (1999) 2.43

Intelligence and psychosocial adjustment in velocardiofacial syndrome: a study of 37 children and adolescents with VCFS. J Med Genet (1997) 2.20

22q11 deletion syndrome in adults with schizophrenia. Am J Med Genet (1998) 1.79

Crkl deficiency disrupts Fgf8 signaling in a mouse model of 22q11 deletion syndromes. Dev Cell (2006) 1.55

Phenotype of adults with the 22q11 deletion syndrome: A review. Am J Med Genet (1999) 1.52

Longitudinal analysis of lymphocyte function and numbers in the first year of life in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Clin Diagn Lab Immunol (1999) 1.03

Velocardiofacial syndrome and DiGeorge sequence. J Med Genet (1994) 0.98

Ocular findings in children with a microdeletion in chromosome 22q11.2. Eur J Pediatr (2007) 0.94

Biased T-cell receptor repertoires in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Clin Exp Immunol (2003) 0.91

Velocardiofacial syndrome. Postgrad Med J (1997) 0.86

Intergenerational and intrafamilial phenotypic variability in 22q11.2 deletion syndrome subjects. BMC Med Genet (2014) 0.76

Constitutional growth delay pattern of growth in velo-cardio-facial syndrome: longitudinal follow up and final height of two cases. J Clin Res Pediatr Endocrinol (2008) 0.75

Articles by these authors

Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet (2001) 6.96

Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11. Proc Natl Acad Sci U S A (1995) 5.62

A common molecular basis for rearrangement disorders on chromosome 22q11. Hum Mol Genet (1999) 4.14

Velo-cardio-facial syndrome associated with chromosome 22 deletions encompassing the DiGeorge locus. Lancet (1992) 4.07

Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. Science (1995) 3.29

Psychotic illness in patients diagnosed with velo-cardio-facial syndrome and their relatives. J Nerv Ment Dis (1994) 3.12

Late-onset psychosis in the velo-cardio-facial syndrome. Am J Med Genet (1992) 3.10

Velo-cardio-facial syndrome: a review of 120 patients. Am J Med Genet (1993) 2.93

Molecular definition of 22q11 deletions in 151 velo-cardio-facial syndrome patients. Am J Hum Genet (1997) 2.85

Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop. J Clin Endocrinol Metab (2008) 2.74

Increasing the efficacy of physician-delivered smoking interventions: a randomized clinical trial. J Gen Intern Med (1991) 2.56

Discrepancies in the use of medications: their extent and predictors in an outpatient practice. Arch Intern Med (2000) 2.42

Metabolic responses to selective beta-adrenergic stimulation in man. Postgrad Med J (1975) 2.38

Prospective randomized trial of polyglactin 910 mesh to prevent recurrence of cystoceles and rectoceles. Am J Obstet Gynecol (2001) 2.31

Directly observed therapy in an inner city hospital. Int J Tuberc Lung Dis (1998) 2.25

AT-rich palindromes mediate the constitutional t(11;22) translocation. Am J Hum Genet (2000) 2.21

Confirmation that the velo-cardio-facial syndrome is associated with haplo-insufficiency of genes at chromosome 22q11. Am J Med Genet (1993) 2.21

Molecular definition of the 22q11 deletions in velo-cardio-facial syndrome. Am J Hum Genet (1995) 2.19

Prevalence and correlates of diabetes in national schizophrenia samples. Schizophr Bull (2000) 2.11

Detection of two viral genomes in single cells by double-label hybridization in situ and color microradioautography. Science (1985) 2.09

Growth hormone therapy of Turner's syndrome: beneficial effect on adult height. J Pediatr (1998) 1.99

Evaluation and outcome measures in the treatment of female urinary stress incontinence: International Urogynecological Association (IUGA) guidelines for research and clinical practice. Int Urogynecol J Pelvic Floor Dysfunct (2007) 1.95

Turner's syndrome. Lancet (2001) 1.94

Fasting glucose insulin ratio: a useful measure of insulin resistance in girls with premature adrenarche. J Clin Endocrinol Metab (2001) 1.88

Diagnostic ultrasound: effects on the DNA and growth patterns of animal cells. Radiology (1979) 1.75

Bipolar spectrum disorders in patients diagnosed with velo-cardio-facial syndrome: does a hemizygous deletion of chromosome 22q11 result in bipolar affective disorder? Am J Psychiatry (1996) 1.71

FGFR2 exon IIIa and IIIc mutations in Crouzon, Jackson-Weiss, and Pfeiffer syndromes: evidence for missense changes, insertions, and a deletion due to alternative RNA splicing. Am J Hum Genet (1996) 1.70

Health characteristics and medical service use patterns of sheltered homeless and low-income housed mothers. J Gen Intern Med (1998) 1.62

Traffic particles and occurrence of acute myocardial infarction: a case-control analysis. Occup Environ Med (2009) 1.57

Three-year follow-up of borderline congenital hypothyroidism. J Pediatr (2000) 1.56

Bayesian analysis for a single 2 x 2 table. Stat Med (1997) 1.50

Association of codon 108/158 catechol-O-methyltransferase gene polymorphism with the psychiatric manifestations of velo-cardio-facial syndrome. Am J Med Genet (1996) 1.49

Changes in mortality and morbidities among infants born at less than 25 weeks during the post-surfactant era. Arch Dis Child Fetal Neonatal Ed (2005) 1.48

Premature adrenarche--normal variant or forerunner of adult disease? Endocr Rev (2000) 1.47

Smoking cessation and severity of disease: the Coronary Artery Smoking Intervention Study. Health Psychol (1992) 1.46

Multiple adnexal tumors and a parotid basal cell adenoma. J Am Acad Dermatol (1991) 1.44

Velo-cardio-facial syndrome: frequency and extent of 22q11 deletions. Am J Med Genet (1995) 1.43

Retinopathy of prematurity. Diagnosis, severity, and natural history. Ophthalmology (1987) 1.43

Cost-effective treatment of asthma. N J Med (1996) 1.39

Craniofacial, limb, and abdominal anomalies in a distinct syndrome: relation to the spectrum of Pfeiffer syndrome type 3. Am J Med Genet (1993) 1.39

Progressively intractable seizures, focal alopecia, and hemimegalencephaly. Neurology (1994) 1.38

The impact of marital status on survival after an acute myocardial infarction: a population-based study. Am J Epidemiol (1983) 1.37

Increasing frequency of staphylococcal infective endocarditis. Experience at a university hospital, 1981 through 1988. Arch Intern Med (1990) 1.36

The effect of spinal immobilization on healthy volunteers. Ann Emerg Med (1994) 1.34

Changes in hospital antibiotic therapy after a quality-of-use study. Lancet (1977) 1.33

Genetic structure at range edge: low diversity and high inbreeding in Southeast Asian mangrove (Avicennia marina) populations. Mol Ecol (2006) 1.32

Pre-diagnostic symptom recognition and help seeking among cancer patients. J Community Health (1990) 1.30

Effects of a computerized working memory training program on working memory, attention, and academics in adolescents with severe LD and comorbid ADHD: a randomized controlled trial. J Child Psychol Psychiatry (2012) 1.28

Transient congenital hypoparathyroidism: resolution and recurrence in chromosome 22q11 deletion. J Pediatr (1996) 1.27

A randomised controlled trial evaluating the effects of two workstation interventions on upper body pain and incident musculoskeletal disorders among computer operators. Occup Environ Med (2006) 1.27

Hospital discharge instructions: comprehension and compliance among older adults. J Gen Intern Med (2014) 1.27

Current age of onset of puberty. Pediatrics (2000) 1.26

Determinants of health and service use patterns in homeless and low-income housed children. Pediatrics (1998) 1.26

Investigation of the action patterns of pectinmethylesterase isoforms through kinetic analyses and NMR spectroscopy. Implications In cell wall expansion. J Biol Chem (1998) 1.24

Treatment of retinal detachment with congenital optic pit by krypton laser photocoagulation. Graefes Arch Clin Exp Ophthalmol (1987) 1.23

Serum androgens as a continuing index of adequacy of treatment of congenital adrenal hyperplasia. J Clin Endocrinol Metab (1978) 1.22

Schizophrenia and chromosomal deletions within 22q11.2. Am J Hum Genet (1995) 1.21

High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group. J Clin Endocrinol Metab (2000) 1.19

Time trends in prognosis of patients with myocardial infarction: a population-based study. Johns Hopkins Med J (1979) 1.19

Genetic heterogeneity of Saethre-Chotzen syndrome, due to TWIST and FGFR mutations. Am J Hum Genet (1998) 1.16

Duodenal atresia presenting as hematemesis in a premature infant with Down syndrome. Case report and review of the literature. J Perinatol (1992) 1.16

Radial distribution pattern of pectin methylesterases across the cambial region of hybrid aspen at activity and dormancy. Plant Physiol (2000) 1.16

Normative data for adrenal steroidogenesis in a healthy pediatric population: age- and sex-related changes after adrenocorticotropin stimulation. J Clin Endocrinol Metab (1991) 1.16

Further delineation of Weaver syndrome. J Pediatr (1986) 1.15

A common breakpoint on 11q23 in carriers of the constitutional t(11;22) translocation. Am J Hum Genet (1999) 1.15

Affectedness and direct objects: the role of lexical semantics in the acquisition of verb argument structure. Cognition (1991) 1.14

The Taskforce 2000 survey on medical education in sleep and sleep disorders. Sleep (1998) 1.13

Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia, II: convergent/discriminant validity and diagnostic group comparisons. Am J Psychiatry (1999) 1.13

Microsatellite analysis of genetic structure in the mangrove species Avicennia marina (Forsk.) Vierh. (Avicenniaceae). Mol Ecol (2000) 1.12

Seven years of safety and efficacy of the recombinant human growth hormone Omnitrope in the treatment of growth hormone deficient children: results of a phase III study. Horm Res (2009) 1.12

Floppy eyelid syndrome and blepharochalasis. Am J Ophthalmol (1986) 1.12

Molecular analysis of velo-cardio-facial syndrome patients with psychiatric disorders. Am J Hum Genet (1997) 1.08

Nasal pyriform aperture stenosis and the holoprosencephaly spectrum. Int J Pediatr Otorhinolaryngol (1994) 1.07

Heart disease in native Americans. Cardiology (1991) 1.07

Epidemiology of obstructive sleep apnea. Epidemiol Rev (1994) 1.06

Male-to-male transmission of Robinow's syndrome. Its occurrence in association with cleft lip and cleft palate. Am J Dis Child (1982) 1.06

Ocular findings in the facioauriculovertebral sequence (Goldenhar-Gorlin syndrome). Am J Ophthalmol (1985) 1.05

Abnormal sex differentiation. J Pediatr (1984) 1.05

Use of leuprolide acetate response patterns in the early diagnosis of pubertal disorders: comparison with the gonadotropin-releasing hormone test. J Clin Endocrinol Metab (1994) 1.05

Diagnosis and treatment of growth hormone deficiency in children and adolescents: towards a consensus. Ten years after the Availability of Recombinant Human Growth Hormone Workshop held in Pisa, Italy, 27-28 March 1998. Horm Res (1998) 1.04

Serologic detection of a y-linked gene in xx males and xx true hermaphrodites. N Engl J Med (1976) 1.04

Normal genes for the cholesterol side chain cleavage enzyme, P450scc, in congenital lipoid adrenal hyperplasia. J Clin Invest (1991) 1.04

A chronobiologic abnormality in luteinizing hormone secretion in teenage girls with the polycystic-ovary syndrome. N Engl J Med (1983) 1.04

Isolation of a new clathrin heavy chain gene with muscle-specific expression from the region commonly deleted in velo-cardio-facial syndrome. Hum Mol Genet (1996) 1.04

Short children, anxious parents: is growth hormone the answer? Hastings Cent Rep (1984) 1.04

Hyperinsulinemia and decreased insulin-like growth factor-binding protein-1 are common features in prepubertal and pubertal girls with a history of premature pubarche. J Clin Endocrinol Metab (1997) 1.03

Bayley-Pinneau method of height prediction in girls with central precocious puberty: correlation with adult height. J Pediatr (1995) 1.03

Progressive adrenal failure in polyglandular autoimmune disease. J Clin Endocrinol Metab (1982) 1.03

MR imaging of soft tissues adjacent to orthopaedic hardware: techniques to minimize susceptibility artefact. Clin Radiol (1997) 1.03

X-linked nephrogenic diabetes insipidus: from the ship Hopewell to RFLP studies. Am J Hum Genet (1992) 1.02

Local recurrence after curative resection of colorectal adenocarcinoma. Surgery (1990) 1.02

Peritonitis after gastrostomy tube replacement in the emergency department. J Emerg Med (2000) 1.01

The diagnosis and management of rectal cancer: expert discussion and recommendations derived from the 9th World Congress on Gastrointestinal Cancer, Barcelona, 2007. Ann Oncol (2008) 1.01